الرئيسية » Education » Renzo Galanello » Renzo Galanello Fellowship Programme 2016

Renzo Galanello Fellowship Programme 2016

We feel extremely privileged and delighted to provide the official completion report of the last TIF – Renzo Galanello Fellowship which took place between 3rd of October – 30th of November 2016 through the Joint Red Cell Unit of the Haematology Department of the University College London Hospital (UCLH) in the UK. We are greatly indebted to the specialist’s team at the UCLH – members of TIF’s International Expert Advisory Panel – for this invaluable contribution both in the materialization of this effort as well as for their support throughout the years to TIF’s educational

We are greatly indebted to the specialist’s team at the UCLH – members of TIF’s International Expert Advisory Panel – for this invaluable contribution both in the materialization of this effort as well as for their support throughout the years to TIF’s educational programme towards improving quality care standards across the world. Furthermore, we are indebted to Novartis Pharma who supports this fellowship as well as to all the medical specialists and health care professionals who have contributed to this initiative. Looking forward to the next training period in October 2017 for yet another unique training experiences. Sincerely yours Panos Englezos President, Thalassaemia International Federation President, Cyprus Alliance for Rare Disorders Honorary President, Pancyprian Thalassaemia Association Dr Androulla Eleftheriou BSC, MSc, PhD Executive Director, Thalassaemia International Federation Executive Director, Cyprus Alliance for Rare Disorders Head of the World Health Organisation (WHO) Collaborating Centre for Thalassaemia Control in Cyprus. Dr Michael Angastiniotis Medical Advisor, Thalassaemia International Federation

We are greatly indebted to the specialist’s team at the UCLH – members of TIF’s International Expert Advisory Panel – for this invaluable contribution both in the materialization of this effort as well as for their support throughout the years to TIF’s educational programme towards improving quality care standards across the world. Furthermore, we are indebted to Novartis Pharma who supports this fellowship as well as to all the medical specialists and health care professionals who have contributed to this initiative. Looking forward to the next training period in October 2017 for yet another unique training experiences.

Sincerely,

Panos Englezos President, Thalassaemia International Federation
President, Cyprus Alliance for Rare Disorders
Honorary President, Pancyprian Thalassaemia Association

Dr. Androulla Eleftheriou
BSC, MSc, PhD
Executive Director, Thalassaemia International Federation
Executive Director, Cyprus Alliance for Rare Disorders
Head of the World Health Organisation (WHO) Collaborating Centre for Thalassaemia Control in Cyprus.

Dr. Michael Angastiniotis
Medical Advisor, Thalassaemia International Federation